Printer Friendly

Phage Therapy for Antibiotic-Resistant Infections Stops Many Amputations.

LOS ALTOS, Calif. -- First Bacteriophage Therapy Clinic in the Western World Now Open

Phage International Inc. announced today that Phage Therapy Center, Tbilisi, Republic of Georgia, is expanding operations with the opening of Phage Therapy Center, Mexico. Patients with infected wounds that are resistant to antibiotics may now travel to PTC's new clinic in Tijuana, Mexico.

Infected wounds not responding to antibiotics often result in limb amputations. In the United States, lower limb amputations for those with diabetic foot ulcers total approximately 65,000 amputations each year, and those with difficult-to-treat infected wounds number in the 100s of thousands.

Phages or bacteriophage are bacteria-specific viruses that invade the bacterial cells. Lytic phages disrupt bacterial metabolism and cause the bacterium to lyse. Like antibiotics, lytic phages have remarkable antibacterial activity.

Potential patients may visit www.phagetherapycenter.com to find out more details.

"PTC treats antibiotic-resistant infections and has saved people from amputation. Our clinic specializes in situations where bacteriophage therapy tends to be superior to standard antibiotic therapy in the US and Western Europe. Conditions treated include: Diabetic foot ulcers, Tropic ulcers, Osteomyelitis, Bedsores, Burns, Gingivitis, Parodontosis, Stomatitis, and drug-resistant infections such as MRSA, VRE, and others. We are proud to be able to bring Phage Therapy technology to Latin America. Bacteriophage technology has proven to be successful in dealing with even the most difficult of infections," said Vakhtang Beridze, PTC Georgia.

"We are delighted to be involved in helping to commercialize phage technology. The opening of Phage Therapy Center Mexico is the first step in making Phage therapy more widely available and is the first clinic to provide Phage therapy in the Western World. We will soon be providing training programs for western physicians and RN wound care specialists," said Ronald Goossens, President of PII.

Phage Therapy Center Georgia, a wholly owned subsidiary of PII, is a privately held medical clinic offering bacteriophage therapy to patients from across the globe.

Phage International, Inc. -- Los Altos, CA, a primary enabler of phage therapy, was formed in July of 2004. Its focus is bacteriophage human therapy to combat drug-resistant pathogens as well as to provide cost effective treatment for non-resistant pathogens. The company is in the process of opening a number of clinics.

www.phageinternational.com
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 5, 2005
Words:374
Previous Article:Cold Stone Creamery Hosts Month-Long Fundraiser to Benefit the Make-A-Wish Foundation; Free Ice Cream Cake at the Fourth Annual World's Largest Ice...
Next Article:JSE Securities Exchange SA and Accenture Sign Multi-Year Technology Agreements; South Africa's Bourse to Become More Agile, Efficient.


Related Articles
Viruses that slay bacteria draw new interest.
Decreased Susceptibility to Ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom.
Viruses stop antibiotic-resistant bacteria. (Science News of the week).
Multiply resistant (MR) Salmonella enterica serotype Typhimurium DT 12 and DT 120: a case of MR DT 104 in disguise? (Dispatches).
Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities. (1).
Efficacy and durability of Bacillus anthracis bacteriophages used against spores. (Features).
Salmonella Agona harboring genomic island 1-A.
Multidrug-resistant strains of Salmonella enterica Typhimurium, United States, 1997-1998 (1).

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters